| Literature DB >> 26999424 |
Neha Korde1,2, Yong Zhang2, Kelsey Loeliger3, Andrea Poon3, Olga Simakova4, Adriana Zingone2, Rene Costello2, Richard Childs3, Pierre Noel5, Samuel Silver6, Mary Kwok7, Clifton Mo7, Neal Young3, Ola Landgren1,2, Elaine Sloand3, Irina Maric5.
Abstract
Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24%) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: anaemia; monoclonal gammopathy of undetermined significance; myeloma; plasmacytosis; pure red cell aplasia
Mesh:
Substances:
Year: 2016 PMID: 26999424 PMCID: PMC5549779 DOI: 10.1111/bjh.14012
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998